Pierluigi Paracchi

Co-Founder &
Venture Consultant

20 years as a Leader in Venture Capital, Financial industry, and as Biotech Entrepreneur in the Italian market

-Founder & CEO of Quantica, the first Italian VC firm exclusively dedicated to research and academic spin-out companies

– Best Biotech Deal: EOS – Ethical Oncology Science, acquired by Clovis Oncology for 420M$ + 80M$ upfront (return 12x; IRR>70%)

– Others deals: Academica Life Science (return 1.4x; IRR>25%) Banzai Group 250M€ IPO (return 2.2x; IRR>14.5%) Gelesis (120M$ raised)

– Principia Fund (managed by Quantica) is the top performer fund in the last 15 years in the Italian VC market

-Venture Consultant at Sofinnova Partners, Sofinnova Capital Fund VII, 240M€ u.m.

-Co-Founder and CEO of Genenta Science, spin-out from San Raffaele Hospital: gene therapy for tumor treatment. Series A, 10M€ and partnership with Amgen (NASDAQ: AMGN)

-Independent Member of the Research and Innovation Commission at the Italian Ministry of Health

-Board Member at Assobiotec and Chairman of the SMEs group